Genetic and reproductive strategies to prevent mitochondrial diseases
Human Reproduction Update · 01.07.2025 · 31 (4) · 269-306
DOI: 10.1093/humupd/dmaf004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Human Reproduction Update, online erschienen am 14.03.2025. Verfasst von Noemi Castelluccio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ghent-Fertility And Stem cell Team (G-FaST), Department for Reproductive Medicine, Department of Human Structure and Repair, Ghent University Hospita…. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Reproductive Techniques, Assisted. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 373 Literaturangaben. Gefördert von: Fonds voor Wetenschappelijk Onderzoek, Fundamental Research, Neuromusculair en Mitochondrieel Onderzoek.
Abstract (Originalsprache)
Mitochondrial DNA (mtDNA) diseases pose unique challenges for genetic counselling and require tailored approaches to address recurrence risks and reproductive options. The intricate dynamics of mtDNA segregation and heteroplasmy shift significantly impact the chances of having affected children. In addition to natural pregnancy, oocyte donation, and adoption, IVF-based approaches can reduce the risk of disease transmission. Prenatal diagnosis (PND) and preimplantation genetic testing (PGT) remain the standard methods for women carrying pathogenic mtDNA mutations; nevertheless, they are not suitable for every patient. Germline nuclear transfer (NT) has emerged as a novel therapeutic strategy, while mitochondrial gene editing has increasingly become a promising research area in the field. However, challenges and safety concerns associated with all these techniques remain, highlighting the need for long-term follow-up studies, an improved understanding of disease mechanisms, and personalized approaches to diagnosis and treatment. Given the inherent risks of adverse maternal and child outcomes, careful consideration of the balance between potential benefits and drawbacks is also warranted. This review will provide critical insights, identify knowledge gaps, and underscore the importance of advancing mitochondrial disease research in reproductive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ghent-Fertility And Stem cell Team (G-FaST), Department for Reproductive Medicine, Department of Human Structure and Repair, Ghent University Hospital, Ghent, Belgium.
- Juno Genetics Italy, Rome, Italy.
- Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.
- Department of Translational Genomics, Mental Health and Neuroscience Research Institute, Maastricht University, Maastricht, The Netherlands.
- FutureNeuro Research Ireland Centre for Translational Brain Science, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
- Juno Genetics UK, Oxford, UK.
ORCID-Profile: Noemi Castelluccio, Heidi Mertes, Björn Heindryckx
Förderung
- Fonds voor Wetenschappelijk Onderzoek
- Fundamental Research
- Neuromusculair en Mitochondrieel Onderzoek
- Toegepast Biomedisch onderzoek met een primair Maatschappelijke finaliteit
Zitieren
APA
Castelluccio, N., Spath, K., Li, D., De Coo, I. F. M., Butterworth, L., Wells, D., Mertes, H., Poulton, J., & Heindryckx, B. (2025). Genetic and reproductive strategies to prevent mitochondrial diseases. Human Reproduction Update, 31(4), 269-306. https://doi.org/10.1093/humupd/dmaf004
Vancouver
Castelluccio N, Spath K, Li D, De Coo IFM, Butterworth L, Wells D, et al. Genetic and reproductive strategies to prevent mitochondrial diseases. Human Reproduction Update. 2025;31(4):269-306. doi:10.1093/humupd/dmaf004
BibTeX
@article{Castelluccio2025,
author = {Castelluccio, Noemi and Spath, Katharina and Li, Danyang and De Coo, Irenaeus F M and Butterworth, Lyndsey and Wells, Dagan and Mertes, Heidi and Poulton, Joanna and Heindryckx, Björn},
title = {Genetic and reproductive strategies to prevent mitochondrial diseases},
journal = {Human Reproduction Update},
year = {2025},
volume = {31},
number = {4},
pages = {269--306},
doi = {10.1093/humupd/dmaf004}
}
EUVIMED